AlzeCure Pharma AB (publ)
SSE:ALZCUR.ST
2.49 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Assets: | |||||||
Current Assets: | |||||||
Cash & Cash Equivalents
| 29.1 | 25.577 | 41.741 | 112.434 | 182.499 | 234.549 | 53.952 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 29.1 | 25.577 | 41.741 | 112.434 | 182.499 | 234.549 | 53.952 |
Net Receivables
| 2.508 | 1.928 | 2.46 | 3.425 | 2.464 | 2.612 | 1.753 |
Inventory
| -0.003 | -0.002 | -0.002 | -0.003 | -0.002 | -2.612 | -1.753 |
Other Current Assets
| 0.003 | 0.002 | 0.002 | 0.003 | 0.002 | 2.612 | 1.753 |
Total Current Assets
| 31.608 | 27.505 | 44.201 | 115.859 | 184.963 | 237.161 | 55.705 |
Non-Current Assets: | |||||||
Property, Plant & Equipment, Net
| 0.376 | 0.852 | 1.422 | 1.944 | 1.768 | 0.597 | 0.242 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.017 | 0.017 | 0.017 | 0.017 | 0.017 | 0.017 | 0.017 |
Goodwill and Intangible Assets
| 0.017 | 0.017 | 0.017 | 0.017 | 0.017 | 0.017 | 0.017 |
Long Term Investments
| 0 | 0.007 | 0.007 | 0.007 | 0.007 | 0.007 | 0.007 |
Tax Assets
| 0 | -0.007 | -0.007 | -0.007 | -0.007 | -0.007 | -0.007 |
Other Non-Current Assets
| -0 | 42.462 | 0.007 | 0.007 | 0.007 | 0.007 | 0.007 |
Total Non-Current Assets
| 0.393 | 43.331 | 1.446 | 1.968 | 1.792 | 0.621 | 0.266 |
Total Assets
| 32.001 | 70.836 | 45.647 | 117.827 | 186.755 | 237.782 | 55.971 |
Liabilities & Equity: | |||||||
Current Liabilities: | |||||||
Account Payables
| 2.687 | 4.845 | 5.971 | 3.966 | 2.997 | 3.646 | 1.332 |
Short Term Debt
| 0 | 0 | 0 | 0 | 0 | -0.4 | -1.843 |
Tax Payables
| 1.918 | 1.875 | 1.534 | 0.904 | 0.343 | 0.149 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0.4 | 1.843 |
Other Current Liabilities
| 5.54 | 5.509 | 6.702 | 3.106 | 1.751 | 0.967 | 2.814 |
Total Current Liabilities
| 8.227 | 10.354 | 12.673 | 7.072 | 4.748 | 4.613 | 4.146 |
Non-Current Liabilities: | |||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| -0 | 4.845 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| -0 | 4.845 | 0 | 0 | 0 | 0 | 0 |
Total Liabilities
| 8.227 | 10.354 | 12.673 | 7.072 | 4.748 | 4.613 | 4.146 |
Equity: | |||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 10.822 |
Common Stock
| 1.552 | 1.268 | 0.944 | 0.944 | 0.944 | 0.944 | 0.189 |
Retained Earnings
| -340.218 | -303.051 | -246.812 | -169.031 | -97.665 | -46.807 | -10.822 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0.284 | 0 | 0 | 0 | 0 | -10.822 |
Other Total Stockholders Equity
| 362.44 | 361.981 | 278.842 | 278.842 | 278.728 | 279.032 | 62.458 |
Total Shareholders Equity
| 23.774 | 60.482 | 32.974 | 110.755 | 182.007 | 233.169 | 51.825 |
Total Equity
| 23.774 | 60.482 | 32.974 | 110.755 | 182.007 | 233.169 | 51.825 |
Total Liabilities & Shareholders Equity
| 32.001 | 70.836 | 45.647 | 117.827 | 186.755 | 237.782 | 55.971 |